GSK announces launch of Herpes Zoster vaccine Shingrix in Malaysia

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) has announced the launch of its Herpes Zoster vaccine, Shingrix, ...

September 13, 2024 | Friday | News
BIOCHINA 2025: China’s Largest Bio Convention to Host Over 3,000 Biotech Companies

Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...

September 12, 2024 | Thursday | News
French firm Osivax grants rights to KM Biologics to develop and market influenza vaccine in Japan

Osivax, a FRance-based biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly...

September 10, 2024 | Tuesday | News
Moderna’s COVID-19 mRNA vaccine targeting SARS-COV-2 Variant JN.1 receives approval in Taiwan

Moderna, Inc. has announced that the Taiwan Food & Drug Administration (FDA) has approved an updated formulation of ...

September 4, 2024 | Wednesday | News
mRNA as novel active ingredient – PlasmidFactory providing the template for tomorrow’s vaccines

  Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...

September 2, 2024 | Monday | News
Bavarian Nordic receives approval of Smallpox and Mpox vaccine in Singapore

Danish firm Bavarian Nordic A/S has announced that Singapore’s medicines regulatory authority, Health Sciences Aut...

August 27, 2024 | Tuesday | News
New $3.3 M lab in Australia to design and manufacture cancer vaccines

A new facility at The University of Queensland (UQ) is set to provide Australian researchers with cancer vaccines tailor...

July 29, 2024 | Monday | News
Korea announces KRW 55 B funding for five years to develop vaccine storage technology, therapeutics

Korea's Ministry of Health and Welfare and the Korea Health Industry Development Institute (KHIDI) recent...

July 27, 2024 | Saturday | News
Korea's SK bioscience invests $2 M in US biotech startup Sunflower Therapeutics

SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a Simple Agreement for F...

July 25, 2024 | Thursday | News
CEPI backs Valneva with $41.3 M funding to increase access to world’s first Chikungunya vaccine

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and French biotech firm Valneva SE, have expanded th...

July 24, 2024 | Wednesday | News
Canada reveals intention to join International Vaccine Institute in Korea

Mélanie Joly, Canada’s Minister of Foreign Affairs, visited the International Vaccine Institute’s (IV...

July 23, 2024 | Tuesday | News
Indian Immunologicals donates anti-rabies vaccine to economically backward provinces of Vietnam

Indian Immunologicals Ltd (IIL), led by its Chairman Dr Meenesh Shah and Managing Director Dr K. Anand Kumar, has donate...

July 16, 2024 | Tuesday | News
Mitsubishi to promote Moderna's mRNA respiratory vaccine portfolio in Japan

Moderna, Inc. and Mitsubishi Tanabe Pharma Corporation  have entered into a joint agreement regarding the co-promot...

July 10, 2024 | Wednesday | News
Merck inks MoU with Afrigen Biologics for development of mRNA vaccine technology platform

Merck, a leading science and technology company, has announced that its life science business sector has entered a...

July 3, 2024 | Wednesday | News
Korea strengthens efforts for development & clinical trials of infectious disease vaccines

South Korea-based International Vaccine Institute (IVI) has signed a memorandum of understanding (MoU) with the Catholic...

July 3, 2024 | Wednesday | News
Gavi to boost access to life-saving human rabies vaccines in over 50 countries

Gavi, the Vaccine Alliance, in collaboration with partners, has announced support for human rabies vaccines for post exp...

June 13, 2024 | Thursday | News
Korea-Africa partnership for vaccine research and development

The International Vaccine Institute (IVI) has exchanged a trilateral Memorandum of Understanding (MoU) with the Korea Ad...

June 11, 2024 | Tuesday | News
Australia-US ink $32 M partnership for vaccine discovery & development

Queensland will be a major international hub for vaccine discovery and development with a $32 million partnership secure...

June 4, 2024 | Tuesday | News